Salvador
Martín Algarra
Consultor Médico
Instituto Valenciano de Oncologia
Valencia, EspañaInstituto Valenciano de Oncologia-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2017
-
Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)
Annals of Translational Medicine, Vol. 5, Núm. 19
2016
-
Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach
Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 1044-1050
-
GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases
Annals of Oncology, Vol. 27, pp. vi383
-
Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience
Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1147-1157
-
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: A retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study
Melanoma Research, Vol. 26, Núm. 3, pp. 278-283
2015
-
Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study
PLoS ONE, Vol. 10, Núm. 4
2005
-
Clinical practice guidelines on antiemetics in oncology
Expert Review of Anticancer Therapy, Vol. 5, Núm. 6, pp. 963-972